JP2001512451A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001512451A5 JP2001512451A5 JP1998535351A JP53535198A JP2001512451A5 JP 2001512451 A5 JP2001512451 A5 JP 2001512451A5 JP 1998535351 A JP1998535351 A JP 1998535351A JP 53535198 A JP53535198 A JP 53535198A JP 2001512451 A5 JP2001512451 A5 JP 2001512451A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9703101.7 | 1997-02-14 | ||
| GB9703100.9 | 1997-02-14 | ||
| GB9703099.3 | 1997-02-14 | ||
| GBGB9703101.7A GB9703101D0 (en) | 1997-02-14 | 1997-02-14 | Formulations |
| GBGB9703099.3A GB9703099D0 (en) | 1997-02-14 | 1997-02-14 | Formulations |
| GBGB9703100.9A GB9703100D0 (en) | 1997-02-14 | 1997-02-14 | Formulations |
| PCT/EP1998/000811 WO1998035672A1 (en) | 1997-02-14 | 1998-02-10 | Pharmaceutical formulations comprising amoxocyllin and clavulanate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001512451A JP2001512451A (ja) | 2001-08-21 |
| JP2001512451A5 true JP2001512451A5 (cg-RX-API-DMAC7.html) | 2005-10-06 |
Family
ID=27268719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53535198A Ceased JP2001512451A (ja) | 1997-02-14 | 1998-02-10 | アモキシシリンおよびクラブラン酸塩を含む医薬処方 |
Country Status (25)
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9416600D0 (en) * | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
| WO1997009042A1 (en) | 1995-09-07 | 1997-03-13 | Smithkline Beecham Corporation | Pharmaceutical formulation |
| GB9815532D0 (en) * | 1998-07-17 | 1998-09-16 | Lek Pharmaceutical & Cvhemical | Pharmaceutical suspension formulation |
| WO2000050036A1 (en) * | 1999-02-26 | 2000-08-31 | Biovail International Ltd. | Storage stable amoxycillin and clavulanate suspension composition |
| US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
| US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
| JP4880125B2 (ja) * | 1999-04-13 | 2012-02-22 | ビーチャム・ファーマシューティカルズ・（プライベイト）・リミテッド | 新規治療法 |
| PT1078627E (pt) * | 1999-08-20 | 2006-10-31 | Glaxosmithkline Lab Sas | Formulacao farmaceutica compreendendo amoxicilina e clavulanato |
| FR2797588B1 (fr) * | 1999-08-20 | 2003-08-01 | Smithkline Beecham Lab | Formulation pharmaceutique a base d'amoxycilline et de clavulanate |
| US6541025B1 (en) * | 1999-12-30 | 2003-04-01 | Shear/Kershman Laboratories, Inc. | Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| US6375982B1 (en) * | 2000-07-05 | 2002-04-23 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and method of using same |
| US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
| WO2002030392A2 (en) | 2000-10-12 | 2002-04-18 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
| AT413983B (de) * | 2001-04-12 | 2006-08-15 | Sandoz Ag | K-clavulanat in der form eines granulates |
| AT412344B (de) * | 2001-04-12 | 2005-01-25 | Sandoz Ag | Hydrophobisierte teilchen von k-clavulanat |
| AU2003208358A1 (en) * | 2002-02-01 | 2003-09-02 | Sandoz Gmbh | Demixing-stable granulate |
| KR20050005437A (ko) * | 2002-04-09 | 2005-01-13 | 플라멜 테크놀로지스 | 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제 |
| WO2004006917A1 (en) * | 2002-07-16 | 2004-01-22 | Ranbaxy Laboratories Limited | Dispersible tablets for oral administration |
| AU2004246811A1 (en) * | 2003-06-16 | 2004-12-23 | Glaxo Group Limited | Pharmaceutical formulations comprising amoxicillin and clavulanate |
| CN1968682A (zh) * | 2004-06-18 | 2007-05-23 | 株式会社柳韩洋行 | 包含表面改性的碳酸氢钠的阿莫西林和/或克拉维酸口服分散片组合物 |
| SI21912A (sl) * | 2004-12-24 | 2006-06-30 | Lek Farmacevtska Druzba D.D. | Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino |
| DE102006007830A1 (de) * | 2006-02-17 | 2007-08-30 | Grünenthal GmbH | Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure |
| CN100464750C (zh) * | 2006-02-23 | 2009-03-04 | 珠海联邦制药股份有限公司 | 一种制备含阿莫西林钠和克拉维酸钾的药物混合物的方法 |
| FI20080351A0 (fi) * | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi |
| US8951562B2 (en) | 2006-11-10 | 2015-02-10 | Atacama Labs Oy | Method and apparatus or dry granulation |
| FI20080352A0 (fi) * | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi |
| FI20070521L (fi) | 2006-11-10 | 2008-05-11 | Atacama Labs Oy | Rakeita, tabletteja ja rakeistusmenetelmä |
| CA2723409C (en) | 2008-05-09 | 2016-11-08 | Atacama Labs Oy | Method and apparatus for dry granulation |
| CN102861015B (zh) * | 2011-07-05 | 2015-07-08 | 北京乐维生物技术有限公司 | 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺 |
| WO2014065769A1 (en) * | 2012-10-22 | 2014-05-01 | Bilgiç Mahmut | Formulations for oral suspensions comprising antibiotics |
| PL3046548T3 (pl) | 2013-09-20 | 2020-07-13 | Centrient Pharmaceuticals Netherlands B.V. | Tabletka zawierająca krospowidon |
| US9254261B2 (en) * | 2014-03-03 | 2016-02-09 | Sandoz Ag | Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid |
| KR102002906B1 (ko) * | 2016-10-18 | 2019-07-23 | 경동제약 주식회사 | 셀레콕시브를 포함하는 정제 |
| EP3994154A1 (en) | 2019-07-05 | 2022-05-11 | GlaxoSmithKline Intellectual Property (No.2) Limited | Streptomyces clavuligerus |
| CN113274357B (zh) * | 2021-05-28 | 2022-12-27 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种阿莫西林药物及其制备方法 |
| CN114869884A (zh) * | 2021-07-30 | 2022-08-09 | 江苏恒丰强生物技术有限公司 | 一种用于猪呼吸道疾病的复方阿莫西林粉及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4110165A (en) * | 1974-04-20 | 1978-08-29 | Beecham Group Limited | Process for the production of clavulanic acid |
| US4140764A (en) * | 1974-12-18 | 1979-02-20 | Beecham Group Limited | β-Lactamase inhibitors and process for their preparation |
| JO984B1 (en) * | 1977-10-11 | 1979-12-01 | بيتشام غروب ليمتد | A dry pharmaceutical compound with a suitable dosage unit for oral administration |
| NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
| GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
| WO1994016696A1 (en) * | 1993-01-22 | 1994-08-04 | Smithkline Beecham Plc | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
| IL109770A0 (en) * | 1993-05-29 | 1994-11-28 | Smithkline Beecham Corp | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby |
| GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
| GB9405856D0 (en) * | 1994-03-24 | 1994-05-11 | Smithkline Beecham Plc | Pharmaceutical formulation |
| GB9407386D0 (en) * | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
| GB9408117D0 (en) * | 1994-04-23 | 1994-06-15 | Smithkline Beecham Corp | Pharmaceutical formulations |
| DZ1926A1 (fr) * | 1994-09-03 | 2002-02-17 | Smithkline Beckman P L C | Formulations pharmaceutiques. |
-
1998
- 1998-02-10 AT AT98912303T patent/ATE243516T1/de not_active IP Right Cessation
- 1998-02-10 EA EA199900647A patent/EA002595B1/ru not_active IP Right Cessation
- 1998-02-10 EP EP98912303A patent/EP0975342B1/en not_active Expired - Lifetime
- 1998-02-10 PL PL98334976A patent/PL334976A1/xx unknown
- 1998-02-10 TR TR1999/01961T patent/TR199901961T2/xx unknown
- 1998-02-10 DE DE69815833T patent/DE69815833T2/de not_active Expired - Lifetime
- 1998-02-10 SK SK1102-99A patent/SK110299A3/sk unknown
- 1998-02-10 JP JP53535198A patent/JP2001512451A/ja not_active Ceased
- 1998-02-10 EP EP01201884A patent/EP1142574A1/en not_active Ceased
- 1998-02-10 IL IL13120198A patent/IL131201A/xx not_active IP Right Cessation
- 1998-02-10 CN CNB988040956A patent/CN1194687C/zh not_active Expired - Fee Related
- 1998-02-10 ID IDW990859D patent/ID23673A/id unknown
- 1998-02-10 NZ NZ337043A patent/NZ337043A/en unknown
- 1998-02-10 WO PCT/EP1998/000811 patent/WO1998035672A1/en not_active Ceased
- 1998-02-10 CA CA002280857A patent/CA2280857A1/en not_active Abandoned
- 1998-02-10 BR BR9807383-4A patent/BR9807383A/pt not_active Application Discontinuation
- 1998-02-10 AP APAP/P/1999/001623A patent/AP1253A/en active
- 1998-02-10 AU AU67196/98A patent/AU728526B2/en not_active Ceased
- 1998-02-10 KR KR10-1999-7007362A patent/KR100499812B1/ko not_active Expired - Fee Related
- 1998-02-10 ES ES98912303T patent/ES2201468T3/es not_active Expired - Lifetime
- 1998-02-11 DZ DZ980030A patent/DZ2420A1/xx active
- 1998-02-12 MA MA24964A patent/MA24473A1/fr unknown
-
1999
- 1999-08-12 NO NO993887A patent/NO993887L/no unknown
- 1999-08-13 OA OA9900181A patent/OA11087A/en unknown
- 1999-08-13 BG BG103664A patent/BG103664A/xx unknown
-
2000
- 2000-07-26 HK HK02102072.5A patent/HK1043041A1/en unknown